Cervical Cancer Screening Guidelines (2026 Update)

Cervical cancer screening has changed substantially over the past decade. The "annual Pap" of older guidelines has been replaced by less-frequent testing with better methods (HPV co-testing or primary HPV screening). Here's the current 2026 schedule.

The short answer (US Preventive Services Task Force + ACS recommendations)

These are the current 2026 recommendations from major US guideline bodies, with continued shift toward HPV-first testing.

The three test approaches

Pap smear alone (cytology)

• Examines cervical cells for abnormalities
• Sensitivity: ~50-75% per test
• Specificity: high
• Used as standalone in younger women; in combination later

HPV testing alone (primary HPV screening)

• Detects HPV DNA from high-risk strains
• Sensitivity: 95%+ per test for high-grade lesions
• Allows longer intervals
• Becoming preferred approach
• US guidelines increasingly recommend this for ages 25-65 with extended intervals (5 years)

Co-testing (Pap + HPV together)

• Both tests done on same sample
• Highest sensitivity
• Allows 5-year intervals
• Current standard for ages 30-65

Why screening changed

Older approach (1990s-2000s)

• Annual Pap from age 18
• Yearly anxiety, costs, false positives
• Over-treatment of lesions that would have spontaneously regressed

Current approach (2020s)

• Start at 21 (or 25, depending on guideline)
• Longer intervals
• HPV-based testing
• Less false-positive workup
• Better sensitivity per test

What evidence supports

• HPV testing catches more cancers earlier than Pap alone
• Most HPV infections clear spontaneously — don't need treatment
• Less frequent screening doesn't miss aggressive cancers if testing is done right

What each result means

Pap smear results

• Normal: continue routine screening
• ASC-US (atypical cells of undetermined significance): repeat in 1 year or HPV test
• LSIL (low-grade squamous intraepithelial lesion): colposcopy
• ASC-H (atypical squamous cells - cannot exclude high-grade): colposcopy
• HSIL (high-grade squamous intraepithelial lesion): colposcopy + treatment
• AGC (atypical glandular cells): colposcopy + endometrial sampling

HPV results

• Negative: continue routine screening at appropriate interval
• Positive for high-risk strains (especially 16, 18): colposcopy or genotype reflex testing
• Other high-risk strains positive but 16/18 negative: Pap + close follow-up

Co-test results

• Both negative: 5-year interval
• HPV negative + Pap abnormal: closer follow-up
• HPV positive + Pap normal: typically 1-year repeat
• HPV positive + Pap abnormal: colposcopy

What is colposcopy?

If your Pap or HPV is abnormal, colposcopy is the next step:

• Visual examination of cervix with magnification
• Vinegar (acetic acid) applied to highlight abnormal areas
• Biopsy of any suspicious areas
• Done in office, 15-30 minutes
• Mild discomfort, light bleeding for days after
• Results in days to a week

How is HPV-positive without abnormal Pap managed?

• About 80% of HPV positive cases clear on their own within 1-2 years
• Most don't require intervention
• HPV genotyping (HPV-16 and -18) helps assess risk
• Re-test in 1 year for clearance

Special situations

After HPV vaccination

• Vaccinated women still need screening
• Vaccine covers ~90% of cancer-causing strains, but not all
• Screening schedules are the same regardless of vaccination status (for now)

Pregnancy

• Continue routine screening per usual schedule if due
• Pap can be done in pregnancy (less common to do colposcopy unless clearly needed)
• Defer treatment until after delivery in most cases

HIV+ patients

• More frequent screening recommended
• Often annual Pap
• HPV co-test
• Lower threshold for colposcopy
• May follow specialized HIV+ screening guidelines

Trans men with cervix

• Screening guidelines apply if you have a cervix
• Some affirming providers experienced in this
• Don't skip just because of gender identity

After total hysterectomy with cervix removed

• For benign conditions: discontinue screening
• For high-grade lesion or cancer: continue per oncology guidelines

After CIN2+ treatment

• Surveillance for at least 25 years (often longer)
• More frequent screening
• HPV testing usually post-treatment

What about anal Pap or cervical screening for non-cervix-bearing people?

• Cervix-bearing trans men: cervical screening as above
• High-risk MSM and HIV+ men: anal Pap (see anal cancer screening)
• Vulvar screening: not routine; symptom-driven

When to start screening earlier than 21

Generally not recommended — even with high-risk behavior. The slow progression of cervical cancer + the rarity in teens make pre-21 screening low yield with high false-positive harm.

Exceptions:

• HIV+ at any age
• Immunosuppression
• Symptoms (bleeding, abnormal pelvic exam findings)

When to continue past 65

Continue screening past 65 if:

• Inadequate prior screening (less than 3 negative Pap or 2 negative co-tests in past 10 years)
• High-grade lesion history within past 25 years
• Immunosuppression
• HIV+
• Other risk factors

What if the test is uncomfortable?

The pelvic exam during Pap can be uncomfortable. Tips:

• Communicate to your provider — they can use smaller speculum, more lube
• Breathing exercises
• Ask for explanation of each step
• Bring a friend if it helps
• Some clinics offer self-collected HPV samples (vaginal swab)

At-home HPV testing

Newer options include:

• Self-collected vaginal swabs sent to lab
• FDA approval for primary screening (2024)
• Improving access for women who avoid in-clinic pelvic exams
• Comparable accuracy to clinic-collected samples for HPV detection

Worth asking if available where you live.

How HPV vaccination integrates

• Get vaccinated if eligible (see HPV vaccine for adults over 26)
• Still get screened — vaccine doesn't replace screening
• Vaccinated and screened: highest protection
• New vaccinated cohorts may have less aggressive screening recommendations in future

What HPV strains are screened for

High-risk HPV types covered:

• 16 (highest risk; biggest cancer driver)
• 18
• 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Genotyping usually distinguishes 16, 18, and "other high-risk" since 16 and 18 carry the most risk.

Common confusions

"I had a Pap last year — I don't need it this year." Correct — only if your guideline interval is annual, which it usually isn't now. Confirm with your provider.

"Pap smear and HPV test are the same." No — Pap looks at cells under microscope. HPV test looks for viral DNA. They're often done from the same sample but are different tests.

"If I'm HPV-positive, I have cancer." No — most HPV clears on its own. Persistent HPV-16 over years is what leads to cancer.

"I'm too old for HPV." (50-60s) Not necessarily — older women can still acquire or have persistent HPV. Screen per guidelines.

"I had the HPV vaccine — I don't need to screen." You still need to screen. Vaccine + screening = best protection.

What to ask your provider

"What's my current screening interval given my history?"

"Are we doing Pap, co-test, or primary HPV?"

"If positive HPV but normal Pap, what's the plan?"

"Am I a candidate for at-home self-collected HPV testing?"

"When should I follow up?"

Cost and access

• Covered by most insurance under preventive services
• Title X clinics, Planned Parenthood, free women's health services available
• Self-pay: ~$50-200 for Pap + HPV co-test
• Programs like NBCCEDP (National Breast and Cervical Cancer Early Detection Program) help uninsured women

Bottom line

Current 2026 cervical cancer screening:

• 21-24: Pap every 3 years
• 25-29: Pap or primary HPV every 3-5 years
• 30-65: Co-test every 5 years (preferred) or primary HPV every 5 years or Pap every 3 years
• 65+: Discontinue if adequate prior screening
• HIV+ or immunosuppressed: More frequent
• Pregnancy: Continue as appropriate

The trend: longer intervals, HPV-first testing, more sensitive overall, less anxiety.

Vaccination + screening is the gold standard. Don't skip either.

For related content, see HPV vaccine for adults over 26, HPV and cervical cancer risk, HPV throat cancer, and our HPV pillar guide.